Virtus ETF Advisers’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,656
Closed -$71.1K 710
2024
Q4
$71.1K Buy
5,656
+1,628
+40% +$24.5K 0.03% 363
2024
Q3
$74.4K Buy
4,028
+68
+2% +$1.39K 0.03% 419
2024
Q2
$85.3K Buy
3,960
+897
+29% +$20.6K 0.04% 381
2024
Q1
$82.5K Sell
3,063
-211
-6% -$5.99K 0.04% 389
2023
Q4
$98.1K Sell
3,274
-1,082
-25% -$23.9K 0.06% 367
2023
Q3
$89.3K Sell
4,356
-436
-9% -$7.92K 0.05% 349
2023
Q2
$95.2K Buy
4,792
+351
+8% +$7.09K 0.06% 407
2023
Q1
$76.1K Sell
4,441
-1,713
-28% -$33.5K 0.04% 391
2022
Q4
$120K Sell
6,154
-3,706
-38% -$68.2K 0.06% 413
2022
Q3
$157K Buy
9,860
+68
+0.7% +$1.06K 0.06% 347
2022
Q2
$135K Buy
9,792
+3,000
+44% +$35.8K 0.05% 339
2022
Q1
$108K Sell
6,792
-400
-6% -$6.91K 0.05% 290
2021
Q4
$157K Buy
7,192
+2,686
+60% +$73.3K 0.06% 336
2021
Q3
$135K Sell
4,506
-228
-5% -$8.3K 0.06% 358
2021
Q2
$210K Sell
4,734
-627
-12% -$27.2K 0.09% 312
2021
Q1
$238K Buy
5,361
+100
+2% +$5.49K 0.1% 296
2020
Q4
$289K Sell
5,261
-11,734
-69% -$428K 0.12% 230
2020
Q3
$389K Sell
16,995
-2,315
-12% -$57K 0.2% 174
2020
Q2
$404K Buy
19,310
+2,895
+18% +$52.2K 0.19% 193
2020
Q1
$229K Sell
16,415
-2,391
-13% -$47.3K 0.09% 269
2019
Q4
$428K Buy
18,806
+3,143
+20% +$52.5K 0.07% 235
2019
Q3
$182K Sell
15,663
-872
-5% -$10.8K 0.04% 261
2019
Q2
$248K Sell
16,535
-1,264
-7% -$22.1K 0.05% 277
2019
Q1
$312K Sell
17,799
-1,805
-9% -$28.5K 0.66% 57
2018
Q4
$291K Sell
19,604
-2,170
-10% -$36K 0.05% 119
2018
Q3
$536K Sell
21,774
-15,976
-42% -$347K 0.06% 115
2018
Q2
$741K Buy
+37,750
New +$714K 0.66% 75

Other funds holding RCKT